Screener
ResMed RMD Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from ResMed’s reported figures.
Based on trailing twelve months.
The source filing: ResMed’s 8-K, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Accession
- 0001193125-26-337962
FAQ
- What is ResMed's return on equity?
- ResMed (RMD) reported return on equity of 24.3% in Q2 2026.
- How has ResMed's return on equity changed year-over-year?
- ResMed's return on equity decreased by 6.2% year-over-year, from 25.9% to 24.3%.
- What is the long-term trend for ResMed's return on equity?
- Over 5 years (2021 to 2026), ResMed's return on equity has grown at a 6.6% compound annual growth rate (CAGR), from 17.6% to 24.3%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about ResMed's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude